Patents by Inventor Heung Bae Jeon

Heung Bae Jeon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11884766
    Abstract: Provided is a composition for emulsion polymerization which includes: an asymmetric compound represented by the following Chemical Formula 1; an aromatic vinyl monomer; and a conjugated diene-based monomer, and a rubber compound prepared from the same. (in Chemical Formula 1, X is a C1-C10 alkoxy group.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: January 30, 2024
    Assignees: Korea Kumba Petrochemical Co., Ltd., Pusan National University Industry-University Cooperation Foundation, Kwangwoon University Industry-Academic Collaboration
    Inventors: Jae-Kon Suh, Gwanghoon Kwag, Duseong Ahn, Wonho Kim, Kiwon Hwang, Sanghoon Song, Heung Bae Jeon, Jinyoung Jung, Yuyeong Kang
  • Publication number: 20220127404
    Abstract: Provided is a composition for emulsion polymerization which includes: an asymmetric compound represented by the following Chemical Formula 1; an aromatic vinyl monomer; and a conjugated diene-based monomer, and a rubber compound prepared from the same. (in Chemical Formula 1, X is a C1-C10 alkoxy group.
    Type: Application
    Filed: October 25, 2021
    Publication date: April 28, 2022
    Inventors: Jae-Kon SUH, Gwanghoon KWAG, Duseong AHN, Wonho KIM, Kiwon HWANG, Sanghoon SONG, Heung Bae JEON, Jinyoung JUNG, Yuyeong KANG
  • Patent number: 8106035
    Abstract: The present invention provides novel D-ring and side-chain analogs of 1?,25-dihydroxyvitamin D3, compositions comprising these compounds and methods of using these compounds as selective inhibitors of CYP24. In particular, the compounds of the invention are useful for treating diseases which benefit from a modulation of the levels of 1?,25-dihydroxyvitamin D3, for example, cell-proliferative disorders.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: January 31, 2012
    Assignee: Cytochroma Inc.
    Inventors: Gary H. Posner, Jae Kyoo Lee, Qiang Wang, Kenneth R. Crawford, Hong Woon Yang, Steven M. Silverman, Byung-Chul Suh, Jay A. White, Glenville Jones, Uttam Saha, Heung Bae Jeon
  • Patent number: 6982258
    Abstract: The present invention provides novel 16-ene-C25-oxime and 16-ene-C-25-oxime ether analogs of 1?,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compound of Formula I are useful for treating diseases which benefit from a modulation of the levels of 1?,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: January 3, 2006
    Assignees: Cytochroma Inc., Johns Hopkins University
    Inventors: Gary Posner, Mehmet Kahraman, Heung Bae Jeon, Jay A. White, Glenville Jones, Bethany Halford
  • Publication number: 20040224930
    Abstract: The present invention provides novel D-ring and side-chain analogs of 1&agr;,25-dihydroxyvitamin D3, compositions comprising these compounds and methods of using these compounds as selective inhibitors of CYP24. In particular, the compounds of the invention are useful for treating diseases which benefit from a modulation of the levels of 1&agr;,25-dihydroxyvitamin D3, for example, cell-proliferative disorders.
    Type: Application
    Filed: December 18, 2003
    Publication date: November 11, 2004
    Inventors: Gary H. Posner, Jae Kyoo Lee, Qiang Wang, Kenneth R. Crawford, Hong Woon Yang, Steven M. Silverman, Byung-Chul Suh, Jay A. White, Glenville Jones, Uttam Saha, Heung Bae Jeon
  • Publication number: 20030171342
    Abstract: The present invention provides novel 16-ene-C25-oxime and 16-ene-C-25-oxime ether analogs of 1&agr;,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compound of Formula I are useful for treating diseases which benefit from a modulation of the levels of 1&agr;,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.
    Type: Application
    Filed: October 15, 2002
    Publication date: September 11, 2003
    Inventors: Gary Posner, Mehmet Kahraman, Heung Bae Jeon, Jay A. White, Glenville Jones, Bethany Halford